In the News

• USask researchers seek to prevent liver disease, high blood pressure, and understand lifelong impacts of Zika virus

  Mar 23, 2021

  Three University of Saskatchewan researchers have been awarded a total of $1.87 million by the Canadian Institutes for Health Research (CIHR) for projects involving fatty liver disease, high blood pressure, and Zika virus.

• Canada’s Global Nexus and VIDO join forces to combat COVID–19

  Feb 25, 2021

  Canada’s Global Nexus for Pandemics and Biological Threats at McMaster University and VIDO at USask are working together to accelerate vaccine and drug development, human clinical trials and create new diagnostic tools.

• VIDO gains provincial support towards becoming a ‘Centre for Pandemic Research’

  Feb 23, 2021

  The Government of Saskatchewan committed $15 million to support the University of Saskatchewan’s Vaccine and Infectious Disease Organization’s position as a Centre for Pandemic Research.